Newsroom

Interview

Dr. Chantal Bader is the first candidate of the Young AcademiXX program at Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University. After completing her PhD in the HIPS Department Microbial Natural Products, she spent just over two years as a postdoctoral researcher in Ben Shen's group at the Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Florida, USA. She has now returned to Saarbrücken and is laying the foundation for her future scientific career with her participation in the Young AcademiXX program. In this interview, she talks about her connection to HIPS, her plans for the future and how Young AcademiXX is helping her to put them into practice.

18.07.2024

HIPS

Lina Herhaus (top left), Martin Jahn (top right), Milan Gerovac (bottom left) and Natalia Torow (bottom right) are MICROSTAR junior research group leaders at HZI.

News

At the Helmholtz Centre for Infection Research (HZI) in Braunschweig, four young scientists will start their work in late summer and fall 2024 to investigate resilience mechanisms of microbes and humans. As part of the MICROSTAR (Microbial Stargazing) project, Lina Herhaus, Martin Jahn, Milan Gerovac and Natalia Torow were recruited in a highly competitive process. Over an initial period of five years, their research groups will investigate cutting edge issues related to signal transmission in infections, the intestinal microbiome, bacteriophages and the development of immunity.

17.07.2024

HZI Campus

News

CRISPR-Cas systems, defense systems in bacteria, have become a plentiful source of technologies for molecular diagnostics. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg have expanded this extensive toolbox. Their novel method, called PUMA, enables the detection of RNA with Cas12 nucleases, which naturally target DNA. PUMA promises a wide range of applications and high accuracy. The team published its results in the journal Nature Communications.

16.07.2024

HIRI

News

The huge community of microorganisms in our gut keeps us healthy. And when things go wrong, we get sick. And not just a little: Disorders of our microbiome could be the trigger for morbid obesity, diabetes, inflammatory bowel diseases and even depression or cancer. Dr Lisa Osbelt-Block knows this. She conducts research at the HZI in the ‘Microbial Immune Regulation’ research group headed by Prof Till Strowig and is fascinated by our little fellow inhabitants. In this episode of the HZI podcast InFact she talks about how our microbiome keeps our body healthy and what happens when it is not in order. She also talks about current research into the microbiome and how the findings can be used to treat diseases.

16.07.2024

HZI Campus

Dr Nicole Schneider-Daum in the laboratory.

News

The lungs have a very complex structure, which makes it difficult to simulate them in the laboratory using human cell line models. As a result, researchers still rely on animal testing in preclinical studies to develop inhaled drugs. A research team led by Dr Nicole Schneider-Daum of the Department of Drug Delivery across Biological Barriers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has succeeded in establishing a human lung cell line that is suitable for the development of in vitro models. Schneider-Daum's team was awarded the Saarland research prize "Alternatives to animal testing" for this achievement.

15.07.2024

HIPS

News

Bacteria possess unique traits with great potential for benefiting society. However, current genetic engineering methods to harness these advantages are limited to a small fraction of bacterial species. A team led by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now introduced a novel approach that can make many more bacteria amenable to genetic engineering. Their method, called IMPRINT, uses cell-free systems to enhance DNA transformation across various bacterial strains. The findings were published today in the journal Molecular Cell.

26.06.2024

HIRI

Back to the first page
...
17
18
19
20
...
145

HZI in the media

... er Klinischer Direktor des Helmholz Zentrums für Infektionsforschung (HZI) und Gründungsdirektor des Zentrums für Individualisierte ...

21.08.2025

Deutsche Gesellschaft für Innere Medizin e.V.

Nature Medicine

. The CiiM is a joint institution of the Helmholtz Center for Infection Research (HZI) and Hannover Medical School (MHH).

21.08.2025

Medical Xpress

und damit einhergehenden Erkrankungen zu sein.“

Helmholtz-Zentrum für Infektionsforschung

Originalpublikation:

J. Botey-Bataller, N. van

21.08.2025

Verband Deutscher Biologen e.V.

Now, a team of researchers, led by scientists from the Helmholtz Centre for Infection Research in Germany, has reported that a gene in the

21.08.2025

The Hindu

Cicin-Sain, a viral immunologist at Germany's Helmholtz Centre for Infection Research, is leading the development of a respiratory syncytial

16.08.2025

The Times of India

Instituts für Pharmazeutische Forschung Saarland (HIPS), einem gemeinsamen Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) ...

15.08.2025

Springer Medizin

... Einrichtung betreiben die MHH und das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig gemeinsam.

In seine ...

15.08.2025

Neue Presse (Hannover)

Medicine Bundesamt für Verbraucherschutz und Lebensmittelsicherheit Helmholtz-Zentrum für Infektionsforschung ARD alpha Universität Würzburg

13.08.2025

Brisant

... Prof. Dr. rer. nat. Dunja Bruder, Helmholtz-Zentrum für Infektionsforschung, Braunschweig und Institut für Med. Mikrobiologie ...

12.08.2025

Deutsches Ärzteblatt

Register now for the HZI-Newsletter

and stay up to date!

Email address

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.

Please enter here the word as displayed in the picture. This is to prevent spamming.*

If you can't read the word, click here.